Associate Director, Early-Stage Formulation Sciences, Biopharmaceutical Development
AstraZeneca
Clarksburg, Maryland
Neil Mody is a formulation scientist within the dosage form design and development department at AstraZeneca. He has 15+ years of experience with broad expertise in formulation development, physicochemical and process characterization strategies for multiple molecular modalities including peptides, enzymes, fusion proteins, mAbs, multispecifics, circuits and engagers, antibody-drug conjugates and gene therapies. In his current role, Neil is a CMC product team lead, he also oversees a team responsible for leading novel molecule formulation and computational technology development workstreams.
Machine-Learning Prediction of Antibody Aggregation and Viscosity in Formulation Development
Monday, October 23, 2023
3:15 PM – 3:30 PM ET